Found: 22
Select item for more details and to access through your institution.
Women leaders in hematology: Inspirations & insights.
- Published in:
- American Journal of Hematology, 2016, v. 91, p. S6, doi. 10.1002/ajh.24316
- By:
- Publication type:
- Article
Unmet needs in the transition to adulthood: 18- to 30-year-old people with hemophilia.
- Published in:
- American Journal of Hematology, 2015, v. 90, p. S17, doi. 10.1002/ajh.24219
- By:
- Publication type:
- Article
Challenges in transition to adulthood for young adult patients with hemophilia: Quantifying the psychosocial issues and developing solutions.
- Published in:
- American Journal of Hematology, 2015, v. 90, p. S1, doi. 10.1002/ajh.24217
- By:
- Publication type:
- Article
The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study.
- Published in:
- International Journal of Hypertension, 2016, p. 1, doi. 10.1155/2016/2014201
- By:
- Publication type:
- Article
Patient‐reported outcomes and joint status across subgroups of US adults with hemophilia with varying characteristics: Results from the Pain, Functional Impairment, and Quality of Life (P‐FiQ) study.
- Published in:
- European Journal of Haematology, 2018, v. 100, p. 14, doi. 10.1111/ejh.13028
- By:
- Publication type:
- Article
Assessments of pain, functional impairment, anxiety, and depression in US adults with hemophilia across patient‐reported outcome instruments in the Pain, Functional Impairment, and Quality of Life (P‐FiQ) study.
- Published in:
- European Journal of Haematology, 2018, v. 100, p. 5, doi. 10.1111/ejh.13027
- By:
- Publication type:
- Article
Development and Reliability of the Joint Tissue Activity and Damage Examination for Quantitation of Structural Abnormalities by Musculoskeletal Ultrasound in Hemophilic Joints.
- Published in:
- Journal of Ultrasound in Medicine, 2019, v. 38, n. 6, p. 1569, doi. 10.1002/jum.14846
- By:
- Publication type:
- Article
Diabetes, hepatitis C and human immunodeficiency virus influence hypertension risk differently in cohorts of haemophilia patients, veterans and the general population.
- Published in:
- Haemophilia, 2022, v. 28, n. 6, p. e228, doi. 10.1111/hae.14637
- By:
- Publication type:
- Article
Blood pressure in persons with haemophilia with a focus on haemophilia‐specific risk factors.
- Published in:
- Haemophilia, 2022, v. 28, n. 6, p. 977, doi. 10.1111/hae.14614
- By:
- Publication type:
- Article
A phase IV, multicentre, open‐label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures.
- Published in:
- Haemophilia, 2022, v. 28, n. 4, p. e105, doi. 10.1111/hae.14574
- By:
- Publication type:
- Article
Risk of diabetes in haemophilia patients compared to clinic and non‐clinic control cohorts.
- Published in:
- Haemophilia, 2022, v. 28, n. 3, p. 445, doi. 10.1111/hae.14515
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. i, doi. 10.1111/hae.14463
- By:
- Publication type:
- Article
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 911, doi. 10.1111/hae.14418
- By:
- Publication type:
- Article
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 921, doi. 10.1111/hae.14419
- By:
- Publication type:
- Article
Quantitative measurements of haemophilic joint tissues by point‐of‐care musculoskeletal ultrasound: Associations with clinical and functional joint outcome parameters.
- Published in:
- Haemophilia, 2021, v. 27, n. 5, p. 866, doi. 10.1111/hae.14368
- By:
- Publication type:
- Article
Real‐world data demonstrate improved bleed control and extended dosing intervals for patients with haemophilia B after switching to recombinant factor IX Fc fusion protein (rFIXFc) for up to 5 years.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 975, doi. 10.1111/hae.14152
- By:
- Publication type:
- Article
A Prospective Observational Study of Antihemophilic Factor (Recombinant) Prophylaxis Related to Physical Activity Levels in Patients with Hemophilia A in the United States (SPACE).
- Published in:
- Journal of Blood Medicine, 2021, v. 12, p. 883, doi. 10.2147/JBM.S327180
- By:
- Publication type:
- Article
Phase I/II and Phase II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Chemotherapy-resistant Sarcoma and Osteosarcoma.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 9, p. 1651, doi. 10.1038/mt.2009.126
- By:
- Publication type:
- Article
Activity of TNT: a phase 2 study using talimogene laherparepvec, nivolumab and trabectedin for previously treated patients with advanced sarcomas (NCT# 03886311).
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1116937
- By:
- Publication type:
- Article
A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 4, p. 570, doi. 10.1002/cncr.29081
- By:
- Publication type:
- Article
Consistency of serial ultrasonographic joint tissue measurements by the Joint <sub>tissue</sub>Activity and Damage Exam (JADE) protocol in relation to hemophilic joint health parameters.
- Published in:
- BMC Musculoskeletal Disorders, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12891-023-06419-5
- By:
- Publication type:
- Article
SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 906, doi. 10.3390/cancers15030906
- By:
- Publication type:
- Article